Mass Torts

August 5, 2026

Dupixent Lawsuit for T-Cell Lymphoma

Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas. On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.

Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, COPD, bullous pemphigoid, allergic fungal rhinosinusitis, and other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different.

The lawsuits allege that Regeneron and Sanofi failed to warn doctors and patients that cutaneous T-cell lymphoma, often called CTCL, can mimic eczema and that Dupixent may mask, accelerate, or delay diagnosis of an underlying lymphoma. Plaintiffs argue that patients with adult-onset, atypical, or treatment-resistant dermatitis should have been warned to rule out lymphoma before starting Dupixent and to stop and investigate if symptoms worsened or changed during treatment.

August 4, 2026

Ozempic Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis, or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.

Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.

August 4, 2026

Gambling Addiction Lawsuits

by Ronald V. Miller, Jr.

Our lawyers are investigating gambling addiction lawsuits involving DraftKings, FanDuel, BetMGM, Caesars, ESPN Bet, Bet365, Fanatics Sportsbook, Hard Rock Bet, and other online betting platforms. The central allegation is that these companies had the data to identify compulsive gambling behavior and, instead of slowing vulnerable users down, continued to push bonus bets, deposit matches, notifications, VIP offers, profit boosts, parlays, microbets, and personalized promotions.

If you or your child suffered serious harm from online sports betting addiction, the first question is not whether gambling was legal. The first question is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.

If you or someone you love has suffered severe financial and emotional harm because of addiction to online gambling or sports betting, contact our lawyers at 800-553-8082 or get a free, no-obligation online consultation.

August 4, 2026

Paragard IUD Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

Our lawyers are handling Paragard IUD lawsuits for women throughout the United States. These cases allege that the copper IUD can fracture during removal, leaving one or both plastic arms inside the uterus and sometimes forcing the patient to undergo another procedure or surgery.

The federal litigation now includes more than 4,000 filed cases. The first bellwether trial ended in a defense verdict in February 2026. That was a real loss for plaintiffs, and it changed the settlement calculus maybe a bit. But it is just one case, and all that can be turned around with a win in September 2026 when we have the next trial.

So there is no Paragard settlement deal as of August 2026. Our lawyers still believe these claims may eventually be resolved through a negotiated settlement, but the first defense verdict makes it harder to predict when that could happen or what defendants will be willing to pay. We discuss our estimated Paragard settlement values below.

August 4, 2026

Truvada Lawsuit

by Ronald V. Miller, Jr.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

July 31, 2026

Taxotere Eye Injury Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

July 30, 2026

Vaginal Mesh Lawsuit

by Ronald V. Miller, Jr.

Women are still filing vaginal mesh lawsuits and bladder sling lawsuits in 2026, but this is no longer the enormous federal mass tort it was a decade ago. The old federal MDLs have closed. Most legacy claims have been resolved, and the remaining litigation is concentrated in individual cases and state-court dockets, including active Johnson & Johnson and Ethicon pelvic mesh cases in New Jersey.

A viable case now depends less on the history of the prior litigation and more on specific evidence: the manufacturer and product, the date of implantation, mesh erosion or another documented complication, revision surgery, and medical evidence linking the implant to the injury. Our lawyers are currently focused on selected claims involving products from Johnson & Johnson/Ethicon and Coloplast. We are not accepting new Boston Scientific mesh claims.

Substantively updated: July 30, 2026

July 28, 2026

Talc Powder Ovarian Cancer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling baby powder lawsuits in all 50 states in 2026. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women.

This page provides an update on J&J talc powder litigation and discusses the settlement amounts in ovarian cancer lawsuits for victims.

Has the deadline passed for you to file a talcum powder lawsuit? Many who assume the statute of limitations has passed to sue Johnson & Johnson may be wrong. Call us today at 800-553-8082 or get a free and quick case review online.

July 23, 2026

Chlorpyrifos Lawsuits

by Ronald V. Miller, Jr.

Chlorpyrifos lawsuits allege that repeated exposure to this widely used insecticide can contribute to Parkinson’s disease. The people most likely to bring these claims are farmers, pesticide applicators, pest control workers, groundskeepers, greenhouse employees, and others who personally mixed, loaded, sprayed, or cleaned up chlorpyrifos products over months or years.

Chlorpyrifos was sold under trade names that include Dursban, Lorsban, Cobalt, Nufos, Bolton, Stallion, Pilot, Warhawk, and Hatchet. It was used on farms, golf courses, ornamental plants, and residential and commercial properties. Many workers remember the trade name but not the active ingredient. Product identification is therefore one of the first and most important parts of investigating a claim.

If you have Parkinson’s disease after years of working with pesticides, you may have wondered whether that exposure played a role. A December 2025 study gives lawyers and scientists a serious reason to investigate chlorpyrifos. Researchers associated estimated long-term residential exposure near agricultural applications with more than 2.5 times the risk of Parkinson’s disease. They also found Parkinson’s-related brain damage in mice that inhaled chlorpyrifos.

July 14, 2026

Tylenol Autism Lawsuit

by Ronald V. Miller, Jr.

Tylenol autism lawsuits are being filed nationwide with a new Tylenol Autism class action lawsuit – technically an MDL, as we explain below – now certified in federal court.

Another Path For Victims – Baby Food

There may be another path to compensation for some victims. Plaintiffs’ Tylenol lawyers are exploring options in state court (and looking at potential baby food lawsuits for children with autism.. Those lawsuits are gaining new currency after the Tylenol cases faltered in the MDL.